Main Page Winners Norway: Winners

Vaccines (№11629663)

14 dec

Number: 11629663

Country: Norway

Source: TED

PUSH for registration

Share:

Link to original

To view links to the source need to register

Publication date


14-12-2018

Description


  1. Section I
    1. Name and addresses
      Folkehelseinstituttet
      Lovisenberggata 8
      Oslo
      0456
      Norway
      Telephone: +47 21076629
      E-mail: [email protected]
    2. Type of the contracting authority:
      Ministry or any other national or federal authority, including their regional or local subdivisions
    3. Main activity:
      Health
  2. Section II
    1. Scope of the procurement:
      1. Title:

        Rota Virus Vaccine, New Notice

        Reference number: 18/11059
      2. Main CPV code:
        33651600, 33651600
      3. Type of contract:
        Supplies
      4. Short description:

        Publication of contract award.

        The Norwegian Institute of Public Health has held an open tender competition for the procurement of vaccines against the rota virus for the base vaccination of infants in the Norwegian child vaccination programme, starting in Q2 2019. The competition was held as an open tender competition, a one-step process where all interested tenderers can submit a tender. Negotiations were not allowed. The objective of the procurement was to enter into a contract for the delivery of the rota virus vaccines for base vaccination of infants in the Norwegian Child Vaccination Programme. The start of vaccination under the new agreement is anticipated to occur in Q2/Q3 2019.

        The procurement was first announced on 1.6.2018 and then cancelled on 7.6.2018. The Doffin reference numbers to the cancelled competition are 2018-088615 and 2018-347723 respectively. The reasons for the cancellation are in the Doffin notice.

      5. Information about lots:
        This contract is divided into lots: no
      6. Total value of the procurement:
        Value excluding VAT: 74 000 000.00 NOK
    2. Description
      1. Title:
      2. Additional CPV code(s):
        33651600
      3. Place of performance:
        Main site or place of performance:

        Oslo

      4. Description of the procurement:

        The Norwegian Institute of Public Health has held an open tender competition for the procurement of vaccines against the rota virus for the base vaccination of infants in the Norwegian child vaccination programme, starting in Q2 2019. The competition was held as an open tender competition, a one-step process where all interested tenderers can submit a tender. Negotiations were not allowed. The objective of the procurement was to enter into a contract for the delivery of the rota virus vaccines for base vaccination of infants in the Norwegian Child Vaccination Programme. The start of vaccination under the new agreement is anticipated to occur in Q2/Q3 2019. There were five (5) minimum requirements for the vaccine. All the minimum requirements had to be fulfilled.

        The procurement was first announced on 1.6.2018 and then cancelled on 7.6.2018. The Doffin reference numbers to the cancelled competition are 2018-088615 and 2018-347723 respectively. The reasons for the cancellation are in the Doffin notice.

      5. Award criteria:
        Quality criterion - Name: Quality, including safety and effect / Weighting: 50
        Price - Weighting: 50
      6. Information about options:
        Options: no
      7. Information about European Union funds:
        The procurement is related to a project and/or programme financed by European Union funds: no
      8. Additional information:

        With reference to point II.2.7 about Duration, etc. the Norwegian Institute of Public Health emphasises that the agreement duration of 48 months, is a maximum length, but the agreement can be terminated earlier in accordance with provisions in the supply agreement (the contract) point 14.

        With reference to point II.2.6, the Norwegian Institute of Public Health emphasis that the stated value is the maximum value in a loosely estimated value range from 48 000 000 NOK to 74 000 000 NOK.

  3. Section IV
    1. Description:
      1. Type of procedure:
        Open procedure
      2. Information about a framework agreement or a dynamic purchasing system:
        The procurement involves the establishment of a framework agreement
      3. Information about electronic auction:
      4. Information about the Government Procurement Agreement (GPA):
        The procurement is covered by the Government Procurement Agreement: yes
    2. Administrative information:
      1. Previous publication concerning this procedure:
        Notice number in the OJ S: 2018/S 113-258404
      2. Information about termination of dynamic purchasing system:
      3. Information about termination of call for competition in the form of a prior information notice:
  4. Section V
    1. Contract No: 1
      Title:

      Rota Virus Vaccine, New Notice

    2. Award of contract
      1. Date of conclusion of the contract: 2018-10-09
      2. Information about tenders:
        Number of tenders received: 1
        Number of tenders received by electronic means: 1
        The contract has been awarded to a group of economic operators: no
      3. Name and address of the contractor:
        GlaxoSmithKline AS
        930744516
        PO Box 180 Vinderen
        Oslo
        0319
        Norway
        The contractor is an SME: no
      4. Information on value of the contract/lot (excluding VAT):
        Initial estimated total value of the contract/lot: 74 000 000.00 NOK
        Total value of the contract/lot: 1.00 NOK
      5. Information about subcontracting:

  5. Section VI
    1. Additional information

      With reference to point II.2.7 about Duration, etc. the Norwegian Institute of Public Health emphasises that the agreement duration of 48 months, is a maximum length, but the agreement can be terminated earlier in accordance with provisions in the supply agreement (the contract) point 14.

      With reference to point II.2.6, the Norwegian Institute of Public Health emphasis that the stated value is the maximum value in a loosely estimated value range from 48 000 000 NOK to 74 000 000 NOK.

    2. Procedures for review
      1. Review body
        Klagenemnda for offentlige anskaffelser (KOFA)
        Postboks 511 Sentrum
        Bergen
        5805
        Norway
      2. Body responsible for mediation procedures

      3. Service from which information about the review procedure may be obtained

    3. Date of dispatch of this notice
      2018-12-13